↓ Skip to main content

Clinical trials for stem cell therapies

Overview of attention for article published in BMC Medicine, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs
3 blogs
twitter
7 X users
facebook
3 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
365 Dimensions

Readers on

mendeley
387 Mendeley
citeulike
3 CiteULike
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical trials for stem cell therapies
Published in
BMC Medicine, May 2011
DOI 10.1186/1741-7015-9-52
Pubmed ID
Authors

Alan Trounson, Rahul G Thakar, Geoff Lomax, Don Gibbons

Abstract

In recent years, clinical trials with stem cells have taken the emerging field in many new directions. While numerous teams continue to refine and expand the role of bone marrow and cord blood stem cells for their vanguard uses in blood and immune disorders, many others are looking to expand the uses of the various types of stem cells found in bone marrow and cord blood, in particular mesenchymal stem cells, to uses beyond those that could be corrected by replacing cells in their own lineage. Early results from these trials have produced mixed results often showing minor or transitory improvements that may be attributed to extracellular factors. More research teams are accelerating the use of other types of adult stem cells, in particular neural stem cells for diseases where beneficial outcome could result from either in-lineage cell replacement or extracellular factors. At the same time, the first three trials using cells derived from pluripotent cells have begun.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 387 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 5 1%
United States 4 1%
Germany 3 <1%
Korea, Republic of 2 <1%
Canada 2 <1%
India 2 <1%
Switzerland 1 <1%
Brazil 1 <1%
Hungary 1 <1%
Other 4 1%
Unknown 362 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 82 21%
Researcher 65 17%
Student > Bachelor 64 17%
Student > Master 58 15%
Student > Postgraduate 16 4%
Other 52 13%
Unknown 50 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 106 27%
Medicine and Dentistry 73 19%
Biochemistry, Genetics and Molecular Biology 49 13%
Engineering 29 7%
Neuroscience 14 4%
Other 53 14%
Unknown 63 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2017.
All research outputs
#1,313,096
of 23,973,927 outputs
Outputs from BMC Medicine
#918
of 3,643 outputs
Outputs of similar age
#5,203
of 112,371 outputs
Outputs of similar age from BMC Medicine
#7
of 41 outputs
Altmetric has tracked 23,973,927 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,643 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 112,371 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.